These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6878255)

  • 1. Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin.
    Bergrem H; Refvem OK
    Proc Eur Dial Transplant Assoc; 1983; 19():552-7. PubMed ID: 6878255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered prednisolone pharmacokinetics in patients treated with rifampicin.
    Bergrem H; Refvem OK
    Acta Med Scand; 1983; 213(5):339-43. PubMed ID: 6880856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin reduces effectiveness and bioavailability of prednisolone.
    McAllister WA; Thompson PJ; Al-Habet SM; Rogers HJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):923-5. PubMed ID: 6403136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Proc Eur Dial Transplant Assoc; 1983; 20():286-90. PubMed ID: 6361740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].
    Winsel K; Eule H; Werner E; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):253-6. PubMed ID: 4011658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effect of rifampicin administration on steroid-dependent asthma.
    Powell-Jackson PR; Gray BJ; Heaton RW; Costello JF; Williams R; English J
    Am Rev Respir Dis; 1983 Aug; 128(2):307-10. PubMed ID: 6349444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of enhanced alpha-1-acid glycoprotein concentration on protein binding, pharmacokinetics and antiarrhythmic effect of lidocaine in the dog.
    De Rick AF; Belpaire FM; Dello C; Bogaert MG
    J Pharmacol Exp Ther; 1987 Apr; 241(1):289-93. PubMed ID: 3572791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on pharmacokinetics of rifampicin in the body of patients with pulmonary tuberculosis.
    Pawlowska I; Pniewski T
    Arzneimittelforschung; 1979; 29(12):1906-11. PubMed ID: 546432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study on the pharmacokinetics of rifampicin between the old and middle-aged tuberculosis patients].
    Weng FH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):292-4, 319. PubMed ID: 2085859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.
    Frey FJ; Frey BM
    J Lab Clin Med; 1983 Apr; 101(4):593-604. PubMed ID: 6833830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of administrative dosage of cyclosporine during anti-tuberculosis chemotherapy including rifampicin].
    Matsui Y; Akagawa S; Kawashima M; Suzuki J; Masuda K; Tamura A; Nagai H; Nagayama N; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2007 Jul; 82(7):563-7. PubMed ID: 17695786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
    Villikka K; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rifampicin-induced resistance to prednisolone treatment in collagen disease--a pharmacokinetic study].
    Kawai S; Ichikawa Y; Homma M
    Ryumachi; 1984 Feb; 24(1):32-7. PubMed ID: 6740415
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
    Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.